Market Insights Consumer OTC Pharmaceuticals

Eye Care - North America

North America

Revenue in the Eye Care market amounts to €1.38k in 2024. The market is expected to grow annually by 2.22% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,165 in 2024).
In relation to total population figures, per person revenues of €2.69 are generated in 2024.

Key regions: Thailand, Philippines, Indonesia, Canada, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Eye Care market in North America has been experiencing steady growth in recent years. Customer preferences for quality eye care services and products, along with the increasing prevalence of eye-related health issues, have contributed to this trend.

Additionally, local special circumstances and underlying macroeconomic factors have played a role in shaping the market. Customer preferences in North America are driving the growth of the Eye Care market. Consumers prioritize high-quality eye care services and products, including regular eye exams, prescription glasses, contact lenses, and eye care supplements.

This preference for quality is reflected in the increasing demand for advanced technologies and innovative solutions in the market. Customers also value convenience and personalized experiences, leading to the rise of online platforms and telemedicine services in the Eye Care industry. Trends in the market indicate a growing focus on preventive eye care and early detection of eye diseases.

With an aging population and the increasing use of digital devices, there has been a rise in eye-related health issues such as myopia, dry eye syndrome, and age-related macular degeneration. This has led to an increased demand for products and services that address these conditions, such as specialized eyewear, eye drops, and treatments. Additionally, there is a growing interest in natural and organic eye care products, driven by the rising awareness of the potential harmful effects of chemicals and toxins on eye health.

Local special circumstances in North America have also influenced the development of the Eye Care market. The region has a well-established healthcare infrastructure, with a high number of eye care professionals and clinics. This accessibility to eye care services has contributed to the growing demand for eye care products and treatments.

Moreover, the region's strong emphasis on technological advancements and innovation has fostered the development of cutting-edge solutions in the Eye Care industry. Underlying macroeconomic factors have further supported the growth of the Eye Care market in North America. The region has a high disposable income and a strong consumer purchasing power, enabling individuals to invest in their eye health.

Additionally, the increasing prevalence of eye-related health issues has led to a higher demand for eye care products and services, driving market growth. Furthermore, the presence of major players in the region, including leading eyewear brands and pharmaceutical companies, has contributed to the competitive nature of the market. In conclusion, the Eye Care market in North America is experiencing steady growth due to customer preferences for quality eye care services and products, the increasing prevalence of eye-related health issues, local special circumstances, and underlying macroeconomic factors.

The market is expected to continue expanding as consumers prioritize their eye health and seek innovative solutions for their eye care needs.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.